1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Paul Finn: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease ferumoxytol, gadofosveset - Pediatric Congenital Heart Disease | Phase 4 | Completed | Paul Finn | 17 | 2016-04-01 | 2022-12-28 |
Ferrosoferric Oxide (1) · gadofosveset trisodium (1)
United States (1)